

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 5.88162336 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.88162336 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.75254739 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.75254739 |
| 5 | interferon-gamma secretion (GO:0072643) | 5.18733273 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 5.17762573 |
| 7 | cysteine metabolic process (GO:0006534) | 4.90164001 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.87157398 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.81246938 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.73558770 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.73558770 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.73558770 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.73558770 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.73558770 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.73558770 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.73181987 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72317685 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 4.62983105 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.57566377 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 4.51048177 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 4.45897791 |
| 22 | cellular glucuronidation (GO:0052695) | 4.44807362 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44472878 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35730897 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35413809 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.13926853 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.11259785 |
| 28 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 4.10313126 |
| 29 | intestinal absorption (GO:0050892) | 4.07736777 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.07677887 |
| 31 | urea metabolic process (GO:0019627) | 4.05621636 |
| 32 | urea cycle (GO:0000050) | 4.05621636 |
| 33 | tryptophan catabolic process (GO:0006569) | 4.03559617 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 4.03559617 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 4.03559617 |
| 36 | glucuronate metabolic process (GO:0019585) | 4.03240978 |
| 37 | uronic acid metabolic process (GO:0006063) | 4.03240978 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.02075714 |
| 39 | bile acid biosynthetic process (GO:0006699) | 4.01869789 |
| 40 | detection of bacterium (GO:0016045) | 4.01450474 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.99112947 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.99112947 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 3.96020587 |
| 44 | drug catabolic process (GO:0042737) | 3.94737288 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.93815678 |
| 46 | detection of other organism (GO:0098543) | 3.89715110 |
| 47 | drug transmembrane transport (GO:0006855) | 3.89004262 |
| 48 | serine family amino acid metabolic process (GO:0009069) | 3.86802405 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.84673565 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.82900763 |
| 51 | tryptophan metabolic process (GO:0006568) | 3.82160201 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.81972351 |
| 53 | urate metabolic process (GO:0046415) | 3.80736423 |
| 54 | response to peptidoglycan (GO:0032494) | 3.79507876 |
| 55 | glycine metabolic process (GO:0006544) | 3.79098241 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.77576187 |
| 57 | lysine metabolic process (GO:0006553) | 3.77364823 |
| 58 | lysine catabolic process (GO:0006554) | 3.77364823 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 3.76201436 |
| 60 | flavonoid metabolic process (GO:0009812) | 3.75558084 |
| 61 | drug transport (GO:0015893) | 3.70641565 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.68287362 |
| 63 | desmosome organization (GO:0002934) | 3.65167855 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.62136332 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.62136332 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.62041917 |
| 67 | phospholipid efflux (GO:0033700) | 3.61400345 |
| 68 | alpha-linolenic acid metabolic process (GO:0036109) | 3.60559878 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 3.57975538 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 3.56755380 |
| 71 | alpha-amino acid catabolic process (GO:1901606) | 3.56492575 |
| 72 | bile acid metabolic process (GO:0008206) | 3.53931279 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.50758412 |
| 74 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.49914043 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.49777050 |
| 76 | response to nitrosative stress (GO:0051409) | 3.48346731 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.47776235 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.47776235 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 3.47100368 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 3.43488808 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 3.43488808 |
| 82 | folic acid metabolic process (GO:0046655) | 3.38835289 |
| 83 | reverse cholesterol transport (GO:0043691) | 3.36844770 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36115370 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.35985271 |
| 86 | protein carboxylation (GO:0018214) | 3.35985271 |
| 87 | negative regulation of fibrinolysis (GO:0051918) | 3.33892968 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.33867830 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33598111 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33598111 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.32552672 |
| 92 | drug metabolic process (GO:0017144) | 3.31334329 |
| 93 | exogenous drug catabolic process (GO:0042738) | 3.31070598 |
| 94 | regulation of protein activation cascade (GO:2000257) | 3.29680987 |
| 95 | intestinal epithelial cell development (GO:0060576) | 3.25500751 |
| 96 | fatty acid beta-oxidation (GO:0006635) | 3.24647374 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 3.23308987 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.22566656 |
| 99 | hormone catabolic process (GO:0042447) | 3.21098332 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 3.20644966 |
| 101 | thymic T cell selection (GO:0045061) | 3.20050107 |
| 102 | response to muramyl dipeptide (GO:0032495) | 3.18674826 |
| 103 | organic acid catabolic process (GO:0016054) | 3.18562517 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.18562517 |
| 105 | leukocyte aggregation (GO:0070486) | 3.18287122 |
| 106 | positive thymic T cell selection (GO:0045059) | 3.17548114 |
| 107 | fatty acid oxidation (GO:0019395) | 3.17237805 |
| 108 | type I interferon signaling pathway (GO:0060337) | 3.16269044 |
| 109 | cellular response to type I interferon (GO:0071357) | 3.16269044 |
| 110 | xenobiotic catabolic process (GO:0042178) | 3.16184468 |
| 111 | response to type I interferon (GO:0034340) | 3.16111757 |
| 112 | complement activation, alternative pathway (GO:0006957) | 3.15878069 |
| 113 | carnitine metabolic process (GO:0009437) | 3.15303494 |
| 114 | proline metabolic process (GO:0006560) | 3.15103630 |
| 115 | plasma lipoprotein particle assembly (GO:0034377) | 3.14723874 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13618378 |
| 117 | response to host immune response (GO:0052572) | 3.13618378 |
| 118 | lipoprotein metabolic process (GO:0042157) | 3.13128748 |
| 119 | respiratory burst (GO:0045730) | 3.12662934 |
| 120 | regulation of complement activation (GO:0030449) | 3.11629266 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.11596880 |
| 122 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10178590 |
| 123 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09608041 |
| 124 | regulation of fibrinolysis (GO:0051917) | 3.08878153 |
| 125 | glutathione derivative biosynthetic process (GO:1901687) | 3.08872925 |
| 126 | glutathione derivative metabolic process (GO:1901685) | 3.08872925 |
| 127 | tyrosine metabolic process (GO:0006570) | 3.08856908 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.08551752 |
| 129 | sterol homeostasis (GO:0055092) | 3.08353350 |
| 130 | benzene-containing compound metabolic process (GO:0042537) | 3.08127691 |
| 131 | lipid oxidation (GO:0034440) | 3.07988529 |
| 132 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.07564215 |
| 133 | myeloid dendritic cell differentiation (GO:0043011) | 3.06921066 |
| 134 | fatty acid catabolic process (GO:0009062) | 3.05648269 |
| 135 | glutamate metabolic process (GO:0006536) | 3.04503921 |
| 136 | fructose metabolic process (GO:0006000) | 3.04246446 |
| 137 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03483760 |
| 138 | macromolecular complex remodeling (GO:0034367) | 3.03483760 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 3.00279281 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 2.96667122 |
| 141 | detection of external biotic stimulus (GO:0098581) | 2.96199125 |
| 142 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95526601 |
| 143 | response to host (GO:0075136) | 2.95526601 |
| 144 | response to host defenses (GO:0052200) | 2.95526601 |
| 145 | negative thymic T cell selection (GO:0045060) | 2.95182656 |
| 146 | B cell mediated immunity (GO:0019724) | 2.94048094 |
| 147 | positive regulation of B cell differentiation (GO:0045579) | 2.90832080 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.90662232 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88139720 |
| 150 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87782827 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87745056 |
| 152 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86938394 |
| 153 | regulation of T cell tolerance induction (GO:0002664) | 2.86505142 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.85770948 |
| 155 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83580915 |
| 156 | T cell selection (GO:0045058) | 2.82180027 |
| 157 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.80660713 |
| 158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80215753 |
| 159 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.78460754 |
| 160 | pinocytosis (GO:0006907) | 2.76264222 |
| 161 | modulation by symbiont of host cellular process (GO:0044068) | 2.76257694 |
| 162 | negative T cell selection (GO:0043383) | 2.73642906 |
| 163 | pentose-phosphate shunt (GO:0006098) | 2.71285401 |
| 164 | germinal center formation (GO:0002467) | 2.71003145 |
| 165 | regulation of B cell differentiation (GO:0045577) | 2.70653212 |
| 166 | barbed-end actin filament capping (GO:0051016) | 2.69071750 |
| 167 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68323499 |
| 168 | regulation of superoxide anion generation (GO:0032928) | 2.66017084 |
| 169 | positive regulation of interferon-alpha production (GO:0032727) | 2.65738556 |
| 170 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.63400479 |
| 171 | mannose metabolic process (GO:0006013) | 2.61662820 |
| 172 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61067311 |
| 173 | T cell migration (GO:0072678) | 2.60181360 |
| 174 | T-helper 1 type immune response (GO:0042088) | 2.59958778 |
| 175 | tolerance induction (GO:0002507) | 2.59234734 |
| 176 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.58724281 |
| 177 | modulation by virus of host process (GO:0019054) | 2.57734182 |
| 178 | regulation of antigen processing and presentation (GO:0002577) | 2.56331385 |
| 179 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56148865 |
| 180 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56130939 |
| 181 | myeloid cell activation involved in immune response (GO:0002275) | 2.55246617 |
| 182 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54277597 |
| 183 | detection of biotic stimulus (GO:0009595) | 2.54069498 |
| 184 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.51908666 |
| 185 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51843749 |
| 186 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49441250 |
| 187 | negative regulation of phagocytosis (GO:0050765) | 2.48441679 |
| 188 | negative regulation of T cell mediated immunity (GO:0002710) | 2.48340256 |
| 189 | regulation of tolerance induction (GO:0002643) | 2.48317013 |
| 190 | regulation of interferon-alpha production (GO:0032647) | 2.48268158 |
| 191 | cellular extravasation (GO:0045123) | 2.47969541 |
| 192 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46267385 |
| 193 | response to laminar fluid shear stress (GO:0034616) | 2.45304152 |
| 194 | response to protozoan (GO:0001562) | 2.44761106 |
| 195 | response to interleukin-15 (GO:0070672) | 2.44734974 |
| 196 | B cell homeostasis (GO:0001782) | 2.43957486 |
| 197 | protein localization to endosome (GO:0036010) | 2.43227712 |
| 198 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.41991395 |
| 199 | regulation of defense response to virus by virus (GO:0050690) | 2.41535414 |
| 200 | glycosphingolipid catabolic process (GO:0046479) | 2.40734418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.45304055 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.90345047 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.45660308 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10645356 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04313843 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.95894653 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.89210316 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.49220654 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.40018059 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.23645544 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.16548872 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.06587715 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03111728 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.50196028 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47742707 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.40115773 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32286603 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21710726 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.19828662 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19283046 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16706117 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16691102 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07288272 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.07059750 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06830647 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05195354 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.03155339 |
| 28 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02969237 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96233456 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94631418 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90780380 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86681482 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86483931 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84536687 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82316701 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80491501 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80128729 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78532337 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76125300 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75283200 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74249480 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73918346 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.73229048 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.71418196 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71262251 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71031268 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70565398 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67465734 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.66062312 |
| 50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.63899005 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.62556013 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59514362 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57231730 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56332205 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.54137393 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50875888 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49366651 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44857387 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43847837 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42606932 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42397794 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40203546 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40011094 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38747919 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37446243 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37189862 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37010544 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.35384436 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33374115 |
| 70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.33300550 |
| 71 | MYB_26560356_Chip-Seq_TH1_Human | 1.32779240 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32507071 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32053417 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31464540 |
| 75 | MYB_26560356_Chip-Seq_TH2_Human | 1.31331360 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31070357 |
| 77 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.30608689 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30205812 |
| 79 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.30051210 |
| 80 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29642776 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29367309 |
| 82 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29150216 |
| 83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28670947 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27977485 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27416120 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26789991 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26442145 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25140655 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22902119 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22770121 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21604760 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21385014 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20259469 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19872770 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18922121 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16164087 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15430181 |
| 98 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14999519 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14413806 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14372918 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12199957 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10237219 |
| 103 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.09377199 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09158667 |
| 105 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09045795 |
| 106 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08767976 |
| 107 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08361702 |
| 108 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06857107 |
| 109 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05046186 |
| 110 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04995902 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04918316 |
| 112 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04402774 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04004440 |
| 114 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03272969 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02075491 |
| 116 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01900006 |
| 117 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01655186 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00815830 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00384519 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.00071289 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99966020 |
| 122 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99906093 |
| 123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.99468844 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99229213 |
| 125 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97693793 |
| 126 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97693793 |
| 127 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97693793 |
| 128 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96544596 |
| 129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96417296 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95875975 |
| 131 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95283854 |
| 132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95041840 |
| 133 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95011988 |
| 134 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.94750043 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94606934 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94602137 |
| 137 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93701751 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93643225 |
| 139 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92606969 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92553606 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92463082 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92347207 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92338557 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92142961 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91799651 |
| 146 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91347988 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90372503 |
| 148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89802018 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89729222 |
| 150 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88008547 |
| 151 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87753290 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87581381 |
| 153 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87304343 |
| 154 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87162150 |
| 155 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85960541 |
| 156 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85381520 |
| 157 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85192480 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84264660 |
| 159 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84143031 |
| 160 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.83832107 |
| 161 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82653406 |
| 162 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81903607 |
| 163 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.81131734 |
| 164 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80596689 |
| 165 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79090881 |
| 166 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78555202 |
| 167 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78449603 |
| 168 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77945898 |
| 169 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77548708 |
| 170 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77478593 |
| 171 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.77453051 |
| 172 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76778922 |
| 173 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74849186 |
| 174 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.73559258 |
| 175 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72945642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.33694946 |
| 2 | MP0005360_urolithiasis | 6.19735525 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.75178724 |
| 4 | MP0005365_abnormal_bile_salt | 4.45229049 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86359616 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.71079331 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70871179 |
| 8 | MP0009840_abnormal_foam_cell | 3.62245824 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.34084352 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.13734520 |
| 11 | MP0003436_decreased_susceptibility_to | 3.09540942 |
| 12 | MP0003303_peritoneal_inflammation | 3.01609622 |
| 13 | MP0003252_abnormal_bile_duct | 2.79951795 |
| 14 | MP0003195_calcinosis | 2.77995843 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.73910365 |
| 16 | MP0001790_abnormal_immune_system | 2.68357139 |
| 17 | MP0005387_immune_system_phenotype | 2.68357139 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.63916131 |
| 19 | MP0005332_abnormal_amino_acid | 2.58006056 |
| 20 | MP0000685_abnormal_immune_system | 2.57197695 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.56574272 |
| 22 | MP0005671_abnormal_response_to | 2.48238167 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 2.46493550 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.44832009 |
| 25 | MP0001800_abnormal_humoral_immune | 2.43758251 |
| 26 | MP0005025_abnormal_response_to | 2.38488103 |
| 27 | MP0005083_abnormal_biliary_tract | 2.37131890 |
| 28 | MP0002419_abnormal_innate_immunity | 2.30620482 |
| 29 | MP0008260_abnormal_autophagy | 2.26281851 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.20284132 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.20281760 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 2.16775825 |
| 33 | MP0009785_altered_susceptibility_to | 2.15142575 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 2.14088044 |
| 35 | MP0002723_abnormal_immune_serum | 2.12567588 |
| 36 | MP0002420_abnormal_adaptive_immunity | 2.11295070 |
| 37 | MP0001819_abnormal_immune_cell | 2.09646670 |
| 38 | MP0002796_impaired_skin_barrier | 2.06641007 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.96484411 |
| 40 | MP0002254_reproductive_system_inflammat | 1.95805683 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.94391868 |
| 42 | MP0003724_increased_susceptibility_to | 1.89158109 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.86996793 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.84842205 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.80380999 |
| 46 | MP0002398_abnormal_bone_marrow | 1.76360555 |
| 47 | MP0002405_respiratory_system_inflammati | 1.75805825 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.69392295 |
| 49 | MP0009278_abnormal_bone_marrow | 1.68247693 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.67576896 |
| 51 | MP0000716_abnormal_immune_system | 1.67272030 |
| 52 | MP0000609_abnormal_liver_physiology | 1.62644947 |
| 53 | MP0004043_abnormal_pH_regulation | 1.61607785 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.60958090 |
| 55 | MP0006082_CNS_inflammation | 1.58390007 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.58190266 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.58025171 |
| 58 | MP0000490_abnormal_crypts_of | 1.53541480 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.51684279 |
| 60 | MP0000858_altered_metastatic_potential | 1.48597917 |
| 61 | MP0002722_abnormal_immune_system | 1.47502310 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.47467199 |
| 63 | MP0001756_abnormal_urination | 1.45904915 |
| 64 | MP0002429_abnormal_blood_cell | 1.44729041 |
| 65 | MP0001873_stomach_inflammation | 1.44595911 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.43544569 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.43059255 |
| 68 | MP0002098_abnormal_vibrissa_morphology | 1.41859262 |
| 69 | MP0003868_abnormal_feces_composition | 1.41462137 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.40591489 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.38972565 |
| 72 | MP0005310_abnormal_salivary_gland | 1.37210590 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.31352731 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.28498877 |
| 75 | MP0000383_abnormal_hair_follicle | 1.27891153 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 1.26446084 |
| 77 | MP0004510_myositis | 1.24943016 |
| 78 | MP0001764_abnormal_homeostasis | 1.24619416 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.24547559 |
| 80 | MP0001545_abnormal_hematopoietic_system | 1.24482884 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.24482884 |
| 82 | MP0003186_abnormal_redox_activity | 1.22245251 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.21983591 |
| 84 | MP0001851_eye_inflammation | 1.19093936 |
| 85 | MP0003075_altered_response_to | 1.17864574 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.17788852 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.13536464 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 1.13080897 |
| 89 | MP0001853_heart_inflammation | 1.09264292 |
| 90 | MP0002060_abnormal_skin_morphology | 1.08407884 |
| 91 | MP0005501_abnormal_skin_physiology | 1.07884066 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 1.07626156 |
| 93 | MP0000537_abnormal_urethra_morphology | 1.05171384 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 1.04173569 |
| 95 | MP0000462_abnormal_digestive_system | 0.99660564 |
| 96 | MP0005166_decreased_susceptibility_to | 0.95312354 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.95031790 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.94108625 |
| 99 | MP0002132_abnormal_respiratory_system | 0.94048767 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.93782963 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93453047 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.92817118 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.92608084 |
| 104 | MP0000678_abnormal_parathyroid_gland | 0.91551899 |
| 105 | MP0001944_abnormal_pancreas_morphology | 0.91349283 |
| 106 | MP0003693_abnormal_embryo_hatching | 0.91191471 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.90513560 |
| 108 | MP0005408_hypopigmentation | 0.90489995 |
| 109 | MP0003718_maternal_effect | 0.90106298 |
| 110 | MP0003091_abnormal_cell_migration | 0.90058738 |
| 111 | MP0000598_abnormal_liver_morphology | 0.88477306 |
| 112 | MP0000343_altered_response_to | 0.87982523 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.87197487 |
| 114 | MP0004381_abnormal_hair_follicle | 0.85183295 |
| 115 | MP0004233_abnormal_muscle_weight | 0.84542553 |
| 116 | MP0004858_abnormal_nervous_system | 0.82280821 |
| 117 | MP0003448_altered_tumor_morphology | 0.81288407 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.80883593 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.80572926 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.79558536 |
| 121 | MP0000604_amyloidosis | 0.78962062 |
| 122 | MP0003828_pulmonary_edema | 0.78897764 |
| 123 | MP0000377_abnormal_hair_follicle | 0.77979444 |
| 124 | MP0000613_abnormal_salivary_gland | 0.76618876 |
| 125 | MP0005451_abnormal_body_composition | 0.75990096 |
| 126 | MP0009053_abnormal_anal_canal | 0.75540781 |
| 127 | MP0005670_abnormal_white_adipose | 0.74800947 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.74800687 |
| 129 | MP0003283_abnormal_digestive_organ | 0.73506233 |
| 130 | MP0005377_hearing/vestibular/ear_phenot | 0.73438702 |
| 131 | MP0003878_abnormal_ear_physiology | 0.73438702 |
| 132 | MP0005023_abnormal_wound_healing | 0.73320956 |
| 133 | MP0000477_abnormal_intestine_morphology | 0.73272309 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.71028153 |
| 135 | MP0003315_abnormal_perineum_morphology | 0.69964234 |
| 136 | MP0001663_abnormal_digestive_system | 0.69094618 |
| 137 | MP0003866_abnormal_defecation | 0.68941469 |
| 138 | MP0002277_abnormal_respiratory_mucosa | 0.68824289 |
| 139 | MP0000467_abnormal_esophagus_morphology | 0.68192316 |
| 140 | MP0009764_decreased_sensitivity_to | 0.68025117 |
| 141 | MP0003119_abnormal_digestive_system | 0.65717973 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.65112498 |
| 143 | MP0005395_other_phenotype | 0.63060589 |
| 144 | MP0001849_ear_inflammation | 0.62882506 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.62660655 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.62206040 |
| 147 | MP0000427_abnormal_hair_cycle | 0.61500017 |
| 148 | MP0003795_abnormal_bone_structure | 0.60969464 |
| 149 | MP0000579_abnormal_nail_morphology | 0.60854564 |
| 150 | MP0000647_abnormal_sebaceous_gland | 0.60440523 |
| 151 | MP0003183_abnormal_peptide_metabolism | 0.59824409 |
| 152 | MP0005058_abnormal_lysosome_morphology | 0.56755617 |
| 153 | MP0000762_abnormal_tongue_morphology | 0.56086082 |
| 154 | MP0004947_skin_inflammation | 0.55421281 |
| 155 | MP0003953_abnormal_hormone_level | 0.54892499 |
| 156 | MP0003638_abnormal_response/metabolism_ | 0.53850377 |
| 157 | MP0000627_abnormal_mammary_gland | 0.53473370 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.53038776 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.52984478 |
| 160 | MP0009379_abnormal_foot_pigmentation | 0.51194067 |
| 161 | MP0008469_abnormal_protein_level | 0.50443002 |
| 162 | MP0001881_abnormal_mammary_gland | 0.49674563 |
| 163 | MP0009765_abnormal_xenobiotic_induced | 0.49057722 |
| 164 | MP0009763_increased_sensitivity_to | 0.48615500 |
| 165 | MP0005381_digestive/alimentary_phenotyp | 0.48389358 |
| 166 | MP0005376_homeostasis/metabolism_phenot | 0.48050131 |
| 167 | MP0005266_abnormal_metabolism | 0.47541580 |
| 168 | MP0010771_integument_phenotype | 0.47117132 |
| 169 | MP0001664_abnormal_digestion | 0.46392910 |
| 170 | MP0009931_abnormal_skin_appearance | 0.45972301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.03539368 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.50242446 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.36427770 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.25512312 |
| 5 | Xanthomatosis (HP:0000991) | 4.97059227 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.85843740 |
| 7 | Gout (HP:0001997) | 4.53358469 |
| 8 | Hyperglycinuria (HP:0003108) | 4.43475072 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.31289153 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.30171990 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.24218182 |
| 12 | Cellulitis (HP:0100658) | 4.09842095 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.08946485 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01838870 |
| 15 | Deep venous thrombosis (HP:0002625) | 4.01074789 |
| 16 | Hyperammonemia (HP:0001987) | 3.98048598 |
| 17 | Ketosis (HP:0001946) | 3.90620558 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90594221 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.90594221 |
| 20 | Hyperglycinemia (HP:0002154) | 3.89431657 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.77112719 |
| 22 | Ketoacidosis (HP:0001993) | 3.67429187 |
| 23 | Fat malabsorption (HP:0002630) | 3.59986347 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.57293849 |
| 25 | Hypolipoproteinemia (HP:0010981) | 3.53972013 |
| 26 | Agammaglobulinemia (HP:0004432) | 3.47410299 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.44957105 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.44957105 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.44957105 |
| 30 | Abnormality of purine metabolism (HP:0004352) | 3.44250646 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.44135968 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 3.43300179 |
| 33 | Meningitis (HP:0001287) | 3.37310962 |
| 34 | Hypoglycemic seizures (HP:0002173) | 3.35815495 |
| 35 | Malnutrition (HP:0004395) | 3.35724102 |
| 36 | Late onset (HP:0003584) | 3.33246954 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.33030147 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29625398 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.23840181 |
| 40 | Recurrent viral infections (HP:0004429) | 3.21336732 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19498116 |
| 42 | Obstructive lung disease (HP:0006536) | 3.19498116 |
| 43 | Recurrent fungal infections (HP:0002841) | 3.18655945 |
| 44 | Colitis (HP:0002583) | 3.16757728 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14929523 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13184670 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.10016401 |
| 48 | Generalized aminoaciduria (HP:0002909) | 3.08211819 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 3.07716866 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.05957926 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 3.03764680 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00809301 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 3.00211375 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.00211375 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 2.98961249 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.98819628 |
| 57 | Increased IgE level (HP:0003212) | 2.95756277 |
| 58 | Symptomatic seizures (HP:0011145) | 2.92156614 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.85844296 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.85407577 |
| 61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.85157908 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.82647276 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.81584626 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.81344528 |
| 65 | Complement deficiency (HP:0004431) | 2.80082317 |
| 66 | Urticaria (HP:0001025) | 2.78859281 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.78270024 |
| 68 | Hyperglycemia (HP:0003074) | 2.75256419 |
| 69 | Myositis (HP:0100614) | 2.75120694 |
| 70 | Recurrent skin infections (HP:0001581) | 2.74969664 |
| 71 | Hyperuricemia (HP:0002149) | 2.73260240 |
| 72 | Increased purine levels (HP:0004368) | 2.73260240 |
| 73 | Osteomyelitis (HP:0002754) | 2.72788204 |
| 74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70981563 |
| 75 | Lethargy (HP:0001254) | 2.70919808 |
| 76 | Gingivitis (HP:0000230) | 2.69914914 |
| 77 | Epidermoid cyst (HP:0200040) | 2.69130163 |
| 78 | Ileus (HP:0002595) | 2.68867858 |
| 79 | Abdominal distention (HP:0003270) | 2.65709604 |
| 80 | Esophageal varix (HP:0002040) | 2.64221154 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.57128328 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56287277 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55237898 |
| 84 | Steatorrhea (HP:0002570) | 2.52790533 |
| 85 | Orchitis (HP:0100796) | 2.50385812 |
| 86 | Vasculitis (HP:0002633) | 2.50072747 |
| 87 | Hyperactive renin-angiotensin system (HP:0000841) | 2.49848403 |
| 88 | Irritability (HP:0000737) | 2.46679020 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.45137663 |
| 90 | Glycosuria (HP:0003076) | 2.45137663 |
| 91 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43268855 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43268855 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.43176232 |
| 94 | Metabolic acidosis (HP:0001942) | 2.42658108 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.42475242 |
| 96 | Abnormal tarsal ossification (HP:0008369) | 2.41771959 |
| 97 | Onycholysis (HP:0001806) | 2.39802915 |
| 98 | Verrucae (HP:0200043) | 2.39339135 |
| 99 | Papilloma (HP:0012740) | 2.39339135 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.38393865 |
| 101 | Petechiae (HP:0000967) | 2.33786623 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32332822 |
| 103 | Hyperbilirubinemia (HP:0002904) | 2.30858054 |
| 104 | Premature loss of primary teeth (HP:0006323) | 2.29538729 |
| 105 | Pustule (HP:0200039) | 2.27344001 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 2.26273134 |
| 107 | Hydroxyprolinuria (HP:0003080) | 2.26273134 |
| 108 | Sepsis (HP:0100806) | 2.23995156 |
| 109 | Hypercholesterolemia (HP:0003124) | 2.23697304 |
| 110 | Increased serum ferritin (HP:0003281) | 2.23162276 |
| 111 | Skin ulcer (HP:0200042) | 2.22500759 |
| 112 | Alkalosis (HP:0001948) | 2.21739576 |
| 113 | Panhypogammaglobulinemia (HP:0003139) | 2.19762856 |
| 114 | Pancreatitis (HP:0001733) | 2.19285746 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 2.18614170 |
| 116 | Lymphopenia (HP:0001888) | 2.16234832 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 2.15531726 |
| 118 | Loss of speech (HP:0002371) | 2.15387361 |
| 119 | Hypertensive crisis (HP:0100735) | 2.14583495 |
| 120 | Distal lower limb muscle weakness (HP:0009053) | 2.12151673 |
| 121 | Abnormality of complement system (HP:0005339) | 2.10344981 |
| 122 | Vascular calcification (HP:0004934) | 2.10088348 |
| 123 | Stomatitis (HP:0010280) | 2.09685982 |
| 124 | Polygenic inheritance (HP:0010982) | 2.09560069 |
| 125 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08894371 |
| 126 | Purpura (HP:0000979) | 2.08717518 |
| 127 | Increased IgM level (HP:0003496) | 2.08648098 |
| 128 | Insulin resistance (HP:0000855) | 2.08300737 |
| 129 | Recurrent bronchitis (HP:0002837) | 2.07668894 |
| 130 | Restrictive lung disease (HP:0002091) | 2.07513402 |
| 131 | Vomiting (HP:0002013) | 2.06990940 |
| 132 | Joint hemorrhage (HP:0005261) | 2.06492255 |
| 133 | Granulocytopenia (HP:0001913) | 2.04891230 |
| 134 | Abnormality of chloride homeostasis (HP:0011422) | 2.04377875 |
| 135 | Axonal loss (HP:0003447) | 2.04343768 |
| 136 | Hepatocellular carcinoma (HP:0001402) | 2.03133381 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 2.01817318 |
| 138 | Fragile nails (HP:0001808) | 2.01646494 |
| 139 | Retrobulbar optic neuritis (HP:0100654) | 2.01067492 |
| 140 | Optic neuritis (HP:0100653) | 2.01067492 |
| 141 | Emphysema (HP:0002097) | 2.00753746 |
| 142 | Milia (HP:0001056) | 2.00280369 |
| 143 | Protuberant abdomen (HP:0001538) | 1.96857522 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.96061214 |
| 145 | Skin rash (HP:0000988) | 1.95739121 |
| 146 | Spontaneous hematomas (HP:0007420) | 1.95697026 |
| 147 | Nephrolithiasis (HP:0000787) | 1.93771179 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93578144 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.92904650 |
| 150 | Thoracic kyphosis (HP:0002942) | 1.92721942 |
| 151 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.92411857 |
| 152 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.92411857 |
| 153 | Abnormal blistering of the skin (HP:0008066) | 1.91156979 |
| 154 | Spastic diplegia (HP:0001264) | 1.90829008 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.89781667 |
| 156 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89129841 |
| 157 | Upper motor neuron abnormality (HP:0002127) | 1.88890129 |
| 158 | Encephalitis (HP:0002383) | 1.88653496 |
| 159 | Rickets (HP:0002748) | 1.86429453 |
| 160 | Neonatal onset (HP:0003623) | 1.86397573 |
| 161 | Alopecia of scalp (HP:0002293) | 1.86246742 |
| 162 | Glomerulosclerosis (HP:0000096) | 1.86114744 |
| 163 | Abnormality of T cell physiology (HP:0011840) | 1.85929676 |
| 164 | Interstitial pulmonary disease (HP:0006530) | 1.85795432 |
| 165 | Hypergammaglobulinemia (HP:0010702) | 1.85644919 |
| 166 | Chest pain (HP:0100749) | 1.85401794 |
| 167 | IgM deficiency (HP:0002850) | 1.84674225 |
| 168 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84232794 |
| 169 | Vacuolated lymphocytes (HP:0001922) | 1.84200053 |
| 170 | Recurrent pneumonia (HP:0006532) | 1.84148084 |
| 171 | Epistaxis (HP:0000421) | 1.84140286 |
| 172 | Opisthotonus (HP:0002179) | 1.83982871 |
| 173 | Hyperphosphaturia (HP:0003109) | 1.82976258 |
| 174 | Prolonged bleeding time (HP:0003010) | 1.82464425 |
| 175 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81545744 |
| 176 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81545744 |
| 177 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81545744 |
| 178 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80814306 |
| 179 | Hyperacusis (HP:0010780) | 1.79955085 |
| 180 | Pili torti (HP:0003777) | 1.79318864 |
| 181 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79048374 |
| 182 | Progressive neurologic deterioration (HP:0002344) | 1.78793802 |
| 183 | Abnormality of T cells (HP:0002843) | 1.78687306 |
| 184 | Thin bony cortex (HP:0002753) | 1.78407187 |
| 185 | Cardiovascular calcification (HP:0011915) | 1.78049499 |
| 186 | Dehydration (HP:0001944) | 1.77677845 |
| 187 | Cerebral edema (HP:0002181) | 1.77329493 |
| 188 | Vertebral compression fractures (HP:0002953) | 1.76901507 |
| 189 | Megaloblastic anemia (HP:0001889) | 1.76811355 |
| 190 | Woolly hair (HP:0002224) | 1.76477966 |
| 191 | Plantar hyperkeratosis (HP:0007556) | 1.75938264 |
| 192 | Mucopolysacchariduria (HP:0008155) | 1.75457298 |
| 193 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75457298 |
| 194 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75275409 |
| 195 | Recurrent sinusitis (HP:0011108) | 1.73921216 |
| 196 | Abnormality of nail color (HP:0100643) | 1.73636385 |
| 197 | Viral hepatitis (HP:0006562) | 1.73412239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 8.11684861 |
| 2 | BCKDK | 4.34148142 |
| 3 | MAP4K1 | 3.42431185 |
| 4 | ERN1 | 3.19549036 |
| 5 | PRPF4B | 3.00388196 |
| 6 | MAP2K2 | 2.97844580 |
| 7 | SMG1 | 2.91124578 |
| 8 | MAPK15 | 2.83205356 |
| 9 | MST1R | 2.55135833 |
| 10 | FRK | 2.35218188 |
| 11 | RIPK4 | 2.27471724 |
| 12 | IRAK4 | 2.09556631 |
| 13 | RPS6KB2 | 2.07011523 |
| 14 | INSRR | 2.00333831 |
| 15 | PKN2 | 1.99229927 |
| 16 | BLK | 1.92405614 |
| 17 | MAP3K3 | 1.75186702 |
| 18 | FLT3 | 1.68651488 |
| 19 | TBK1 | 1.67582498 |
| 20 | AKT3 | 1.63441787 |
| 21 | FGFR4 | 1.61747300 |
| 22 | ICK | 1.60795248 |
| 23 | TYK2 | 1.57833814 |
| 24 | MAP3K14 | 1.56973587 |
| 25 | ZAP70 | 1.55459285 |
| 26 | SIK1 | 1.53218793 |
| 27 | MET | 1.53000947 |
| 28 | MAP3K10 | 1.50839038 |
| 29 | WNK4 | 1.45588878 |
| 30 | STK38L | 1.45526357 |
| 31 | MST4 | 1.44324041 |
| 32 | FER | 1.44124022 |
| 33 | PASK | 1.44115072 |
| 34 | SRPK1 | 1.43805660 |
| 35 | MAP3K2 | 1.41536417 |
| 36 | MAPKAPK3 | 1.41108506 |
| 37 | JAK3 | 1.40008735 |
| 38 | BTK | 1.39929926 |
| 39 | EPHB2 | 1.39564197 |
| 40 | WNK3 | 1.39545246 |
| 41 | CSK | 1.34949822 |
| 42 | TRIB3 | 1.34462829 |
| 43 | TAOK3 | 1.32270800 |
| 44 | MAP3K13 | 1.31516447 |
| 45 | MAP3K11 | 1.30148691 |
| 46 | IKBKE | 1.28585190 |
| 47 | PTK6 | 1.28302364 |
| 48 | TESK1 | 1.22494824 |
| 49 | FES | 1.21730720 |
| 50 | ERBB4 | 1.21367984 |
| 51 | PTK2 | 1.20972306 |
| 52 | IRAK3 | 1.18522513 |
| 53 | MARK3 | 1.18515683 |
| 54 | CSF1R | 1.13840632 |
| 55 | DYRK1B | 1.09743547 |
| 56 | PRKG2 | 1.09740809 |
| 57 | SIK3 | 1.09113164 |
| 58 | PRKCI | 1.07610520 |
| 59 | SYK | 1.07079305 |
| 60 | BUB1 | 1.03220041 |
| 61 | PIK3CG | 1.02948065 |
| 62 | MAP2K1 | 0.97757964 |
| 63 | LATS1 | 0.97396905 |
| 64 | RIPK1 | 0.94482754 |
| 65 | DYRK3 | 0.93147950 |
| 66 | IKBKB | 0.91935348 |
| 67 | CDC42BPA | 0.91524398 |
| 68 | LRRK2 | 0.91079133 |
| 69 | TTK | 0.88659136 |
| 70 | HCK | 0.88549701 |
| 71 | TNK2 | 0.85853688 |
| 72 | TTN | 0.85683390 |
| 73 | PAK4 | 0.84971610 |
| 74 | MAP3K1 | 0.82554436 |
| 75 | WEE1 | 0.81877947 |
| 76 | KDR | 0.80473213 |
| 77 | EIF2AK3 | 0.80267675 |
| 78 | TESK2 | 0.79667735 |
| 79 | LYN | 0.79187366 |
| 80 | FGR | 0.78622375 |
| 81 | PINK1 | 0.78501132 |
| 82 | JAK1 | 0.78358756 |
| 83 | PDPK1 | 0.78240565 |
| 84 | NEK1 | 0.77410691 |
| 85 | BRAF | 0.76078195 |
| 86 | MAPK11 | 0.75626142 |
| 87 | TLK1 | 0.75344227 |
| 88 | LCK | 0.73846800 |
| 89 | SIK2 | 0.72859938 |
| 90 | MAP3K8 | 0.71704293 |
| 91 | STK16 | 0.68742346 |
| 92 | NME2 | 0.68078862 |
| 93 | MATK | 0.68004663 |
| 94 | PRKD2 | 0.67398051 |
| 95 | SCYL2 | 0.63140646 |
| 96 | LMTK2 | 0.62398617 |
| 97 | STK10 | 0.61332099 |
| 98 | ABL2 | 0.61246106 |
| 99 | PDK1 | 0.60865058 |
| 100 | GRK6 | 0.60053338 |
| 101 | RPS6KC1 | 0.59976609 |
| 102 | RPS6KL1 | 0.59976609 |
| 103 | CDK4 | 0.59945698 |
| 104 | MAP2K6 | 0.59101521 |
| 105 | RPS6KA2 | 0.58620020 |
| 106 | MARK2 | 0.57294875 |
| 107 | BRSK2 | 0.55364004 |
| 108 | JAK2 | 0.54912441 |
| 109 | CAMK2G | 0.54858304 |
| 110 | ITK | 0.54022487 |
| 111 | GSK3A | 0.50676119 |
| 112 | KIT | 0.48276317 |
| 113 | MYLK | 0.47867134 |
| 114 | PDK2 | 0.46664953 |
| 115 | TAOK1 | 0.46654714 |
| 116 | PAK3 | 0.46574386 |
| 117 | MAP2K3 | 0.44739115 |
| 118 | PIM2 | 0.44150277 |
| 119 | PIM1 | 0.43395457 |
| 120 | MTOR | 0.43287214 |
| 121 | CDK7 | 0.42125081 |
| 122 | NME1 | 0.42050929 |
| 123 | RAF1 | 0.41576893 |
| 124 | RPS6KA6 | 0.40721815 |
| 125 | MAPK12 | 0.40100715 |
| 126 | PRKCQ | 0.39897461 |
| 127 | MOS | 0.39617233 |
| 128 | TGFBR2 | 0.38803146 |
| 129 | AURKB | 0.35046045 |
| 130 | ERBB2 | 0.34604263 |
| 131 | RET | 0.34601384 |
| 132 | CDK9 | 0.33562016 |
| 133 | PDK3 | 0.32525342 |
| 134 | PDK4 | 0.32525342 |
| 135 | CDK12 | 0.32321233 |
| 136 | PRKAA2 | 0.31924081 |
| 137 | NEK9 | 0.31610974 |
| 138 | AURKA | 0.31133391 |
| 139 | CDK6 | 0.30637271 |
| 140 | EPHB1 | 0.30231811 |
| 141 | IRAK1 | 0.28791823 |
| 142 | KSR2 | 0.27965091 |
| 143 | CHUK | 0.27805551 |
| 144 | MAP3K9 | 0.27748998 |
| 145 | ARAF | 0.25598269 |
| 146 | EEF2K | 0.24637270 |
| 147 | PIK3CA | 0.24509972 |
| 148 | TAOK2 | 0.23109838 |
| 149 | MAPKAPK2 | 0.22736405 |
| 150 | RPS6KA1 | 0.22043520 |
| 151 | EPHA3 | 0.21821887 |
| 152 | IRAK2 | 0.21010668 |
| 153 | PRKAA1 | 0.20503994 |
| 154 | HIPK2 | 0.20419530 |
| 155 | PLK4 | 0.20321661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44211918 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05642267 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.88477976 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57195239 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.53985823 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.52864186 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.50638937 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44140672 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39199805 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37343635 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.32448531 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31718943 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29924598 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29531110 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26978033 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25977127 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25472669 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25105000 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24082522 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22958509 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22079793 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18934147 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11831286 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.08964829 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.07699310 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.04441107 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01008267 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94148110 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92871352 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91315203 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88232768 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88026145 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86936166 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83145705 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.82977986 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82753893 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78142849 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.77960745 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.77849452 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.74902802 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74785357 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72462565 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66790375 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65519398 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65236872 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.64853820 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.64110356 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.57783138 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57374458 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56367250 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55060069 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54490300 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54425190 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54153303 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52779268 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50898972 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50120009 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49798513 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.49600302 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48781221 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48500402 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.47266098 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45679761 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.41521648 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40351726 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38629778 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34173754 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34018431 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33542170 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30088085 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 1.29518409 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28101713 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28000954 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 1.27172461 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26523838 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25623483 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24205167 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24046762 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 1.23530542 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23222641 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22608409 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22422147 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22017719 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 1.18466255 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 1.18372163 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17901964 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17561965 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14864929 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12472302 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11650911 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 1.10633485 |
| 92 | Malaria_Homo sapiens_hsa05144 | 1.09462716 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08168672 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05523095 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04570217 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04493761 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03298318 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01492885 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00605044 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.99133752 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.99030003 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97942444 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97804988 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93285874 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92753055 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92365199 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92334117 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.92039548 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90560156 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90336315 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88934229 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87953637 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87679389 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.87226049 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87150440 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83687665 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83117840 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79774814 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78695197 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78230685 |
| 121 | Protein export_Homo sapiens_hsa03060 | 0.75355970 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75293354 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73849476 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72854805 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71957443 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69366625 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68346515 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68019743 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67854001 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.67802898 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67379150 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.66572404 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66325315 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65191735 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65111752 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63283397 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62874968 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.61583079 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57877962 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56234115 |
| 141 | Lysine degradation_Homo sapiens_hsa00310 | 0.55739867 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.55417254 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54491037 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.54399189 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54091929 |
| 146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53277275 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52858407 |
| 148 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51559267 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49938526 |
| 150 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49159867 |
| 151 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.47495777 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46946300 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44709461 |
| 154 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43672177 |
| 155 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43260117 |
| 156 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42829697 |
| 157 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41863642 |
| 158 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40976284 |
| 159 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39691553 |
| 160 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38672629 |
| 161 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35444971 |
| 162 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34946664 |
| 163 | Bladder cancer_Homo sapiens_hsa05219 | 0.33640807 |
| 164 | Base excision repair_Homo sapiens_hsa03410 | 0.33486076 |
| 165 | Proteasome_Homo sapiens_hsa03050 | 0.33425860 |
| 166 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31834010 |
| 167 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27564629 |
| 168 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23202610 |
| 169 | Lysosome_Homo sapiens_hsa04142 | 0.22029982 |
| 170 | Prion diseases_Homo sapiens_hsa05020 | 0.19761478 |
| 171 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18825153 |
| 172 | Insulin resistance_Homo sapiens_hsa04931 | 0.17678327 |
| 173 | Tight junction_Homo sapiens_hsa04530 | 0.12399070 |
| 174 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12387460 |
| 175 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11102297 |
| 176 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09064285 |
| 177 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08615260 |
| 178 | Thyroid cancer_Homo sapiens_hsa05216 | 0.06752152 |
| 179 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.05158066 |
| 180 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04826640 |
| 181 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04754268 |
| 182 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04140117 |
| 183 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02778003 |

